modtfi
live
viru
vaccin
felin
infecti
periton
fip
evalu
doubl
blind
placebocontrol
field
trial
two
highrisk
popul
vaccin
found
safe
eficaci
one
popul
cat
low
antibodi
titr
felin
coronaviru
fco
v
time
vaccin
although
clinic
healthi
time
vaccin
retrospect
vaccine
later
came
fip
found
rtpcr
posit
fcov
plasma
show
chang
blood
paramet
consist
earli
stage
fip
conclud
vaccin
protect
cat
low
fcov
antibodi
titr
cat
vaccin
failur
probabl
due
preexist
infect
elsevi
scienc
ltd
felin
infecti
periton
fip
normal
fatal
diseas
cat
caus
infect
felin
coronavirus
fcov
antigen
relat
respiratori
coronaviru
strain
man
hcv
transmiss
gastroenter
viru
tgev
swine
canin
switzerland
infect
fcov
domest
cat
widespread
catteri
cat
cat
access
outdoor
found
five
develop
lethal
fwt
certain
cat
popul
seem
suscept
fip
young
cat
especi
prone
fip
case
affect
cat
younger
month
age
cat
younger
year
genet
disposit
certain
breed
cheetah
cat
live
multiplecathousehold
catteri
cat
shelter
cat
access
outdoor
like
get
expos
fcov
develop
fip
anim
singlecathousehold
clinic
sign
includ
effus
noneffus
granulomat
form
fip
also
appear
togeth
characterist
laboratori
find
fip
accept
decemb
anaemia
neutrophilia
lymphopenia
increas
total
serum
protein
hyperglobulinemia
decreas
low
virul
fcov
type
call
felin
enter
coronaviru
fecv
caus
mild
gastrointestin
respiratori
diseas
mainli
kitten
describ
antibodi
fecv
virul
fipcaus
virus
felin
infecti
periton
viru
fipv
crossreact
author
formul
hypothesi
seroposit
cat
actual
infect
fecv
fipv
mutant
fecv
abil
infect
macrophag
time
molecular
immunolog
differ
known
fecv
fipv
explain
differ
virul
coronavirus
therefor
appear
justifi
gener
design
fcov
consid
everi
fcov
infect
cat
potenti
sever
observ
point
import
role
cell
mediat
immun
cmi
fip
detail
immun
mechan
control
fcov
infect
remain
unknown
experiment
condit
humor
immun
lead
protect
contrari
experiment
fip
infect
seroposit
cat
develop
fip
much
shorter
incub
period
seroneg
control
antibodi
depend
enhanc
ade
thought
occur
virusantibodi
complex
form
bound
fc
receptor
macrophag
macrophag
effici
infect
fc
receptormedi
endocytosi
viru
initi
studi
modifi
live
viru
vaccin
primucel
fip
alreadi
commerci
avail
usa
mani
question
concern
safeti
efficaci
field
condit
still
unansw
safeti
vaccin
confirm
experiment
field
vaccin
cat
show
ade
challeng
high
dose
heterolog
viru
efficaci
vaccin
assess
experiment
condit
trial
safeti
efficaci
vaccin
evalu
field
condit
two
high
risk
popul
preliminari
report
present
fecvfipvworkshop
davi
ca
publish
proceed
studi
perform
placebocontrol
doubl
blind
assay
neither
investig
cat
owner
knew
two
colour
code
vial
contain
vaccin
code
open
investig
veterinarian
cat
owner
cat
termin
month
observ
period
two
popul
high
risk
fcov
infect
fip
includ
trial
first
popul
consist
cat
catteri
fip
problem
catteri
fip
case
occur
last
month
prior
begin
trial
either
catteri
kitten
rehom
new
owner
expect
cat
alreadi
expos
fcov
second
popul
consist
cat
month
age
vaccin
veterinarian
switzerland
alreadi
mention
group
suscept
fip
older
cat
cat
popul
subdivid
two
group
vaccin
placebo
respect
compar
regard
age
sex
breed
live
condit
clinic
healthi
cat
older
week
age
vaccin
pregnant
queen
exclud
studi
week
week
later
cat
vaccin
intranas
either
code
vaccin
placebo
vaccin
two
code
group
kept
separ
h
prevent
spread
vaccin
viru
cat
placebo
group
popul
blood
sampl
collect
vaccin
week
test
felv
fcovantibodi
catteri
cat
haematolog
clinic
chemistri
done
week
cat
vaccin
placebo
group
measur
week
fivtest
carri
week
catteri
cat
sick
cat
blood
sampl
collect
haematolog
clinic
chemistri
felv
fcovantibodi
determin
modifi
live
viru
vaccin
develop
gerber
et
briefli
attenu
cell
cultur
passag
norden
laboratori
felin
kidney
nlfk
cell
line
passag
propag
passag
expos
ultraviolet
irradi
vaccin
shown
induc
iga
antibodi
mucosa
stimul
cell
mediat
immun
serial
vaccin
use
studi
commerci
batch
serial
number
titr
tcid
placebo
consist
supernat
noninfect
nlfk
cell
cultur
vaccin
placebo
provid
manufactur
ident
vial
code
colour
label
code
broken
veterinarian
cat
owner
cat
finish
month
observ
period
characterist
catteri
cat
young
pet
cat
summar
tabl
anim
placebo
vaccin
group
catteri
cat
young
pet
cat
differ
significantli
respect
age
sex
breed
live
condit
antibodi
titr
fcov
measur
indirect
immunofluoresc
use
cell
swine
origin
infect
tgev
antigen
plasma
dilut
test
plasma
sampl
cat
examin
circul
felin
leukemiaviru
felv
plasma
sampl
catteri
cat
also
examin
antibodi
felin
immunodefici
viru
fiv
indirect
immunofluoresc
use
fivinfect
cell
antigen
sampl
posit
fluoresc
result
subject
western
blot
catteri
cat
measur
flow
cytometri
cat
die
fip
plasma
sampl
taken
time
first
vaccin
retrospect
examin
presenc
fcovrna
polymeras
chain
reaction
pcr
mean
haematolog
clinic
chemistri
paramet
vaccin
placebo
group
analys
signific
differ
mannwhitney
u
test
chang
laboratori
valu
obtain
differ
cat
time
examin
wilcoxon
test
frequenc
fcov
antibodi
titr
placebo
vaccin
group
compar
use
test
determin
differ
frequenc
fip
vaccin
placebo
group
exact
test
fisher
result
present
separ
catteri
cat
popul
young
pet
cat
sideeffect
report
vaccin
catteri
cat
summar
tabl
month
observ
cat
vaccin
group
placebo
group
die
due
variou
caus
five
cat
vaccin
group
six
cat
placebo
group
die
due
non
fiprel
caus
case
except
one
cat
vaccin
group
die
month
vaccin
liver
problem
two
cat
placebo
group
die
month
vaccin
due
accid
joint
problem
cat
respect
submit
necropsi
fip
exclud
fip
case
occur
six
catteri
characterist
catteri
cat
die
fip
summar
tabl
cat
though
clinic
healthi
show
chang
blood
paramet
time
vaccin
knowledg
safeti
vaccin
breed
cat
investig
far
neither
experiment
field
condit
therefor
data
collect
queen
kitten
vaccin
summar
tabl
differ
found
paramet
evalu
respect
laboratori
paramet
differ
found
vaccin
group
placebo
group
differ
time
point
haematolog
clinic
chemistri
howev
vaccin
placebo
group
chang
laboratori
paramet
observ
differ
time
point
group
show
decreas
albumin
week
compar
week
increas
plasmaprotein
week
compar
week
data
shown
begin
trial
catteri
cat
test
neg
felv
fivantibodi
cat
vaccin
placebo
group
show
fcov
antibodi
titr
higher
frequenc
fcov
titr
cat
vaccin
placebo
group
differ
time
point
vaccin
week
shown
figur
statist
signific
differ
distribut
fcov
antibodi
titr
vaccin
placebo
group
differ
time
point
vaccin
group
well
placebo
group
show
transient
increas
titr
week
compar
week
follow
decreas
week
compar
week
retrospect
plasma
sampl
collect
cat
time
first
vaccin
store
frozen
submit
rtpcr
fcov
tabl
plasma
sampl
test
three
posit
sideeffect
report
popul
young
pet
cat
summar
tabl
observ
period
popul
month
health
condit
cat
end
observ
period
summar
tabl
thirteen
cat
vaccin
group
cat
placebo
group
die
fip
except
one
group
confirm
necropsi
tabl
two
cat
vaccin
group
alreadi
ill
time
tabl
sampl
test
found
posit
one
cat
shelter
high
fip
incid
cat
vaccin
placebo
cat
vaccin
cat
cat
develop
fip
placebo
vaccin
frequenc
distribut
antibodi
titr
fcov
time
first
vaccin
present
figur
clinic
healthi
young
cat
alreadi
expos
fcov
first
year
life
distribut
ident
vaccin
placebo
group
domest
shorthair
cat
show
statist
significantli
lower
fcov
antibodi
titr
purebr
cat
age
p
oool
figur
cat
placebo
group
show
titr
higher
significantli
higher
risk
develop
fip
next
month
cat
titr
lower
figur
though
seven
cat
vaccin
group
six
placebo
group
felv
posit
time
first
vaccin
three
cat
group
test
posit
observ
period
one
felvposit
cat
vaccin
group
three
placebo
group
die
due
fip
confirm
necropsi
aim
studi
evalu
efficaci
safeti
modifi
live
viru
vaccin
doubleblind
studi
field
condit
two
cat
popul
higher
risk
fip
cat
infect
fcov
develop
lethal
fip
incid
fip
cat
popul
hardli
predict
studi
placebo
vaccin
group
indistinguish
regard
distribut
age
sex
live
condit
statist
signific
differ
laboratori
paramet
haematolog
clinic
chemistri
serolog
subset
observ
time
first
vaccin
therefor
cat
vaccin
placebo
group
probabl
becom
infect
fcov
develop
fip
differ
frequenc
fip
case
chang
laboratori
paramet
must
attribut
vaccin
vaccin
cat
show
acceler
form
fip
tabl
figur
one
catteri
cat
age
month
euthan
day
vaccin
cat
though
clinic
inconspicu
show
growth
retard
compar
litter
mate
anaemia
pcv
increas
total
serum
protein
viremia
fcov
time
first
vaccin
two
young
pet
cat
euthan
day
vaccin
cat
die
day
vaccin
shown
chronic
nasal
discharg
anorexia
treat
antibiot
corticosteroid
last
week
vaccin
fcov
antibodi
titr
high
time
vaccin
retrospect
cat
posit
fcov
rtpcr
cat
die
day
vaccin
also
anorect
time
treat
veterinarian
cat
high
titr
time
vaccin
pcr
posit
two
cat
vaccin
mistak
enter
studi
first
place
remain
studi
sake
complet
studi
repres
real
situat
field
cat
obviou
clinic
sign
may
vaccin
mistak
argu
three
cat
vaccin
induc
acceler
fip
may
happen
howev
incid
fip
case
first
day
vaccin
compar
vaccin
vs
placebo
cat
absolut
differ
cat
vaccin
group
cat
placebo
group
die
time
popul
catteri
cat
preval
fcov
antibodi
especi
high
averag
time
death
vaccin
week
vaccin
group
week
placebo
group
lack
sideeffect
effect
fertil
conclud
vaccin
safe
expect
catteri
cat
show
antibodi
fcov
indic
prior
infect
vaccin
group
also
placebo
group
show
increas
titr
week
compar
week
decreas
week
compar
week
figur
increas
antibodi
could
explain
vaccin
vaccin
group
placebo
group
anim
vaccin
placebo
group
separ
h
vaccin
spread
vaccin
viru
cat
placebo
group
seem
unlik
week
vaccin
collect
second
blood
sampl
antibodi
titr
increas
cat
catteri
fip
case
occur
similar
rise
antibodi
titr
observ
catteri
cat
fip
case
seen
time
period
well
known
stress
influenc
immun
system
therefor
specul
stress
caus
handl
vaccin
collect
blood
sampl
led
weaken
reactiv
persist
fcov
infect
increas
antibodi
titr
surprisingli
clinic
healthi
pet
cat
younger
month
show
antibodi
fcov
figur
purebr
cat
show
higher
titr
frequent
seroposit
fcov
domest
cat
figur
probabl
due
differ
live
condit
purebr
cat
normal
rais
multiplecathousehold
close
contact
cat
wherea
domest
cat
often
kept
singlecathousehold
small
group
vaccin
perform
accord
recommend
manufactur
vaccin
show
overal
efficaci
catteri
cat
view
fact
catteri
fip
case
occur
last
month
prior
studi
conclud
catteri
cat
later
die
fip
observ
period
alreadi
vaccin
volum
number
field
trial
fip
vaccin
fehr
et
al
infect
virul
fcov
vaccin
incub
period
conclus
also
support
fact
cat
show
antibodi
fcov
cat
show
chang
blood
paramet
consist
fip
anaemia
low
serum
albumin
high
serum
protein
high
bilirubin
retrospect
cat
rtpcr
posit
fcov
time
first
vaccin
tabl
vaccin
inauenc
laboratori
paramet
haematolog
clinic
chemistri
subset
data
shown
popul
young
pet
cat
reduct
fip
case
vaccin
cat
observ
first
day
infect
figur
howev
time
point
end
observ
period
vaccin
cat
show
significantli
less
fip
case
one
cat
shelter
incid
fip
vaccin
group
six
cat
placebo
group
nine
cat
conclud
exposur
fcov
extrem
high
cat
anim
vaccin
alreadi
hous
shelter
time
conclud
vaccin
failur
popul
due
previou
infect
fcov
cat
high
fcov
antibodi
titr
time
first
vaccin
higher
exclud
cat
titr
lower
time
first
vaccin
examin
studi
vaccin
significantli
decreas
incid
fip
figur
observ
suggest
low
antibodi
titr
relat
degre
immun
probabl
strong
cellmedi
immun
respons
via
thl
presum
lower
viru
load
compar
cat
titr
higher
interpret
would
also
agreement
find
high
titr
placebo
group
associ
higher
risk
develop
fip
figur
conclud
vaccin
cat
alreadi
infect
fcov
prevent
alter
cours
diseas
howev
vaccin
cat
low
antibodi
titr
seem
effici
find
confirm
result
placebocontrol
trial
seroneg
anim
vaccin
enter
cat
shelter
fip
increas
efficaci
vaccin
chang
husbandri
manag
condit
may
initi
lead
decreas
coronavir
load
experiment
condit
vaccin
fcov
naiv
cat
also
found
reduc
incid
sever
infect
low
virul
virus
call
sinc
everi
fcov
infect
consid
potenti
risk
reduc
infect
vaccin
may
also
help
reduc
fip
incid
cat
placebo
group
titr
show
significantli
higher
risk
develop
fip
follow
month
cat
lower
titr
figur
find
observ
mani
cat
pcr
posit
time
first
vaccin
suggest
alreadi
infect
fcov
vaccin
incub
period
would
explain
vaccin
show
low
efficaci
young
pet
cat
howev
difficult
appli
classic
term
incub
period
fip
accord
pedersen
cowork
virul
mutant
fcov
capabl
infect
macrophag
emerg
spontan
time
fcov
mutat
virus
occur
randomli
conclud
high
viru
load
increas
probabl
mutant
aris
function
immun
system
control
viru
load
low
level
therefor
factor
suppress
immun
respons
may
increas
viru
load
genesi
virul
mutant
thu
cat
develop
fip
mani
month
even
year
fcov
infect
conclus
use
live
modifi
vaccin
fip
found
safe
high
risk
popul
field
condit
efficaci
clearli
shown
cat
low
fcov
antibodi
titr
overal
rather
low
high
risk
popul
optim
efficaci
chang
manag
husbandri
help
prevent
fcov
exposur
prior
vaccin
laboratori
help
well
cat
breeder
veterinarian
cat
owner
particip
trial
cornel
vet
scott
fw
corapi
wv
olsen
cw
evalu
safeti
efficaci
primucellfip
vaccin
felin
hlth
top
fehr
holznagel
e
bolla
et
evalu
safeti
efficaci
modifi
live
fipv
vaccin
field
condit
felin
pratt
pedersen
nc
felin
infecti
periton
felin
enter
coronaviru
infect
part
felin
enter
coronaviru
felin
pratt
